New building being developed at GoCo Health Innovation City
20 August 2019

New health innovation initiative unveiled

GoCo Health Innovation City, a new health innovation cluster in Gothenburg, is one step closer to becoming reality after the development plan was recently approved and a formal partnership between real estate companies Next Step and Vectura, and pharma company AstraZeneca is now in place.

The initiative was officially unveiled at a launch event, held at the development site on 20 August.

“We are at an exciting crossroads right now in Sweden, in which we have the potential to be a true global leader in life science. The political will is there, and we already have numerous forward-thinking companies, organisations, and individuals based in Sweden,” said Matti Ahlqvist, AstraZeneca Gothenburg Site Director in a press release. 

“To take us to the next level, we need to create space for these different companies and perspectives to come together to collaborate and unlock new innovative ideas. That is exactly what GoCo Health Innovation City will do,” he adds.

GoCo Health Innovation City will be an arena for health companies, entrepreneurs, start-ups, academic experts, and designers to co-locate and collaborate. It consists of the current AstraZeneca R&D site, as well as new buildings for new tenants, the first of which is scheduled to open in 2021. 

GoCo Health Innovation City is located in Mölndal, an area where life science companies Dentsply, Wellspect, Essity and Smith & Nephew are already based. It’s also in close proximity to Gothenburg’s universities, the university hospital and Sahlgrenska Science Park, where a new innovation centre is planned to be built. 

    Read more